Cargando…
Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug
OBJECTIVE(S): 4-aminosalicylic acid (4-ASA) is an isomer of mesalazine that has recently been shown to be effective against inflammatory bowel disease (IBD), and more specifically, ulcerative colitis. However, the majority of orally administered 4-ASA is readily and extensively absorbed from the sto...
Autores principales: | Sadeghi, Fatemeh, Eidizade, Atie, Saremnejad, Farinaz, Hadizadeh, Farzin, Khodaverdi, Elham, Akhgari, Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351447/ https://www.ncbi.nlm.nih.gov/pubmed/32695295 http://dx.doi.org/10.22038/ijbms.2020.41152.9736 |
Ejemplares similares
-
Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis
por: Jilani, Jamal A, et al.
Publicado: (2013) -
The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices
por: Kaffash, Ehsan, et al.
Publicado: (2021) -
Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018) -
Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019) -
Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
por: Kim, Wooseong, et al.
Publicado: (2019)